Skip to main content
NCBI home page
Virologica Sinica logoLink to Virologica Sinica
. 2011 Jun 12;26(3):156. doi: 10.1007/s12250-011-3194-9

Characterization of the receptor-binding domain of Ebola glycoprotein in viral entry

Jizhen Wang 1, Balaji Manicassamy 1, Michael Caffrey 2, Lijun Rong 1,✉
PMCID: PMC7091247  PMID: 21667336

Abstract

Ebola virus infection causes severe hemorrhagic fever in human and non-human primates with high mortality. Viral entry/infection is initiated by binding of glycoprotein GP protein on Ebola virion to host cells, followed by fusion of virus-cell membrane also mediated by GP. Using an human immunodeficiency virus (HIV)-based pseudotyping system, the roles of 41 Ebola GP1 residues in the receptor-binding domain in viral entry were studied by alanine scanning substitutions. We identified that four residues appear to be involved in protein folding/structure and four residues are important for viral entry. An improved entry interference assay was developed and used to study the role of these residues that are important for viral entry. It was found that R64 and K95 are involved in receptor binding. In contrast, some residues such as I170 are important for viral entry, but do not play a major role in receptor binding as indicated by entry interference assay and/or protein binding data, suggesting that these residues are involved in post-binding steps of viral entry. Furthermore, our results also suggested that Ebola and Marburg viruses share a common cellular molecule for entry.

Key words: Receptor-binding domain, Ebola virus, Glycoprotein, Viral Entry

Footnotes

Foundation item: National Institutes of Health Grant (AI 059570 and AI077767).

References

  • 1.Alvarez C. P., Lasala F., Carrillo J., et al. C-Type Lectins DC-SIGN and L-SIGN Mediate Cellular Entry by Ebola Virus in cis and in trans. J Virol. 2002;76:6841–6844. doi: 10.1128/JVI.76.13.6841-6844.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Basu A., Li B., Mills D. M., et al. Identification of a small-molecule entry inhibitor for filoviruses. J Virol. 2011;85:3106–3119. doi: 10.1128/JVI.01456-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Brindley M. A., Hughes L., Ruiz A., et al. Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events. J Virol. 2007;81:7702–7709. doi: 10.1128/JVI.02433-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Chan S. Y., Empig C. J., Welte F. J., et al. Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell. 2001;106:117–126. doi: 10.1016/S0092-8674(01)00418-4. [DOI] [PubMed] [Google Scholar]
  • 5.Chandran K., Sullivan N. J., Felbor U., et al. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science. 2005;308:1643–1645. doi: 10.1126/science.1110656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Connor R. I., Chen B. K., Choe S., et al. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 1995;206:935–944. doi: 10.1006/viro.1995.1016. [DOI] [PubMed] [Google Scholar]
  • 7.Dolnik O., Volchkova V., Garten W., et al. Ectodomain shedding of the glycoprotein GP of Ebola virus. Embo J. 2004;23:2175–2184. doi: 10.1038/sj.emboj.7600219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Dube D., Schornberg K. L., Shoemaker C. J., et al. Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry. Proc Natl Acad Sci USA. 2010;107:16637–16642. doi: 10.1073/pnas.1008509107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ebert D. H., Deussing J., Peters C., et al. Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J Biol Chem. 2002;277:24609–24617. doi: 10.1074/jbc.M201107200. [DOI] [PubMed] [Google Scholar]
  • 10.Feldmann H., Volchkov V. E., Volchkova V. A., et al. Biosynthesis and role of filoviral glycoproteins. J Gen Virol. 2001;82:2839–28348. doi: 10.1099/0022-1317-82-12-2839. [DOI] [PubMed] [Google Scholar]
  • 11.He J., Choe S., Walker R., et al. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol. 1995;69:6705–6711. doi: 10.1128/jvi.69.11.6705-6711.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Huang I. C., Bosch B. J., Li F., et al. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J Biol Chem. 2006;281:3198–3203. doi: 10.1074/jbc.M508381200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ito H., Watanabe S., Takada A., et al. Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. J Virol. 2001;75:1576–1580. doi: 10.1128/JVI.75.3.1576-1580.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Jeffers S. A., Sanders D. A., Sanchez A. Covalent modifications of the ebola virus glycoprotein. J Virol. 2002;76:12463–12472. doi: 10.1128/JVI.76.24.12463-12472.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Jiang H., Wang J., Manicassamy B., et al. The role of the charged residues of the GP2 helical regions in Ebola entry. Virol Sin. 2009;24:121–135. doi: 10.1007/s12250-009-3015-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kaletsky R. L., Simmons G., Bates P. Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J Virol. 2007;81:13378–13384. doi: 10.1128/JVI.01170-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kuhn J. H., Radoshitzky S. R., Guth A. C., et al. Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J Biol Chem. 2006;281:15951–15958. doi: 10.1074/jbc.M601796200. [DOI] [PubMed] [Google Scholar]
  • 18.Lee J. E., Fusco M. L., Hessell A. J., et al. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature. 2008;454:177–182. doi: 10.1038/nature07082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Leffel E. K., Reed D. S. Marburg and Ebola viruses as aerosol threats. Biosecur Bioterror. 2004;2:186–191. doi: 10.1089/bsp.2004.2.186. [DOI] [PubMed] [Google Scholar]
  • 20.Leroy E. M., Kumulungui B., Pourrut X., et al. Fruit bats as reservoirs of Ebola virus. Nature. 2005;438:575–576. doi: 10.1038/438575a. [DOI] [PubMed] [Google Scholar]
  • 21.Leroy E. M., Rouquet P., Formenty P., et al. Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science. 2004;303:387–390. doi: 10.1126/science.1092528. [DOI] [PubMed] [Google Scholar]
  • 22.Lin G., Simmons G., Pohlmann S., et al. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J Virol. 2003;77:1337–1346. doi: 10.1128/JVI.77.2.1337-1346.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Manicassamy B., Rong L. Expression of Ebolavirus glycoprotein on the target cells enhances viral entry. Virol J. 2009;6:75. doi: 10.1186/1743-422X-6-75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Manicassamy B., Wang J., Jiang H., et al. Comprehensive Analysis of Ebola Virus GP1 in Viral Entry. J Virol. 2005;79:4793–4805. doi: 10.1128/JVI.79.8.4793-4805.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Manicassamy B., Wang J., Rumschlag E., et al. Characterization of Marburg virus glycoprotein in viral entry. Virology. 2007;358:79–88. doi: 10.1016/j.virol.2006.06.041. [DOI] [PubMed] [Google Scholar]
  • 26.Mpanju O. M., Towner J. S., Dover J. E., et al. Identification of two amino acid residues on Ebola virus glycoprotein 1 critical for cell entry. Virus Res. 2006;121:205–214. doi: 10.1016/j.virusres.2006.06.002. [DOI] [PubMed] [Google Scholar]
  • 27.Naldini L., Blomer U., Gage F. H., et al. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A. 1996;93:11382–11388. doi: 10.1073/pnas.93.21.11382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Neumann G., Feldmann H., Watanabe S., et al. Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol. 2002;76:406–410. doi: 10.1128/JVI.76.1.406-410.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Neumann G., Geisbert T. W., Ebihara H., Daddario-DiCaprio, Feldmann H., Kawaoka Y., et al. Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates. J Virol. 2007;81:2995–2998. doi: 10.1128/JVI.02486-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Pager C. T., Craft W. W., Patch J., Jr, et al. A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L. Virology. 2006;346:251–257. doi: 10.1016/j.virol.2006.01.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Qiu Z., Hingley S. T., Simmons G., et al. Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry. J Virol. 2006;80:5768–5776. doi: 10.1128/JVI.00442-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Saeed M F, Kolokoltsov A A, Albrecht T, et al. 2010. Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog, 6(9).pii: e1001110. [DOI] [PMC free article] [PubMed]
  • 33.Saeed M. F., Kolokoltsov A. A., Freiberg A. N., et al. Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus. PLoS Pathog. 2008;4:e1000141. doi: 10.1371/journal.ppat.1000141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Sanchez A., Kiley M. P., Holloway B. P., et al. Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res. 1993;29:215–240. doi: 10.1016/0168-1702(93)90063-S. [DOI] [PubMed] [Google Scholar]
  • 35.Sanchez A., Trappier S. G., Mahy B. W., et al. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A. 1996;93:3602–3607. doi: 10.1073/pnas.93.8.3602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Sanchez A., Trappier S. G., Stroher U., et al. Variation in the glycoprotein and VP35 genes of Marburg virus strains. Virology. 1998;240:138–146. doi: 10.1006/viro.1997.8902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Schornberg K., Matsuyama S., Kabsch K., et al. Role of endosomal cathepsins in entry mediated by the ebola virus glycoprotein. J Virol. 2006;80:4174–4178. doi: 10.1128/JVI.80.8.4174-4178.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Shimojima M., Takada A., Ebihara H., et al. Tyro3 family-mediated cell entry of ebola and marburg viruses. J Virol. 2006;80:10109–10116. doi: 10.1128/JVI.01157-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Simmons G., Gosalia D. N., Rennekamp A. J., et al. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci USA. 2005;102:11876–11881. doi: 10.1073/pnas.0505577102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Simmons G., Wool-Lewis R. J., Baribaud F., et al. Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J Virol. 2002;76:2518–2528. doi: 10.1128/jvi.76.5.2518-2528.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Simon J. H., Fouchier R. A., Southerling T. E., et al. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells. J Virol. 1997;71:5259–5267. doi: 10.1128/jvi.71.7.5259-5267.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Takada A., Fujioka K., Tsuiji M., et al. Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol. 2004;78:2943–2947. doi: 10.1128/JVI.78.6.2943-2947.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Takada A., Robison C., Goto H., et al. A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci USA. 1997;94:14764–14769. doi: 10.1073/pnas.94.26.14764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Volchkov V. E., Becker S., Volchkova V. A., et al. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology. 1995;214:421–430. doi: 10.1006/viro.1995.0052. [DOI] [PubMed] [Google Scholar]
  • 45.Volchkov V. E., Feldmann H., Volchkova V. A. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A. 1998;95:5762–5767. doi: 10.1073/pnas.95.10.5762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Warren T. K., Warfield K. L., Wells J., et al. Antiviral activity of a small-molecule inhibitor of filovirus infection. Antimicrob Agents Chemother. 2010;54:2152–2159. doi: 10.1128/AAC.01315-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Wilson J. A., Bray M., Bakken R., et al. Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins. Virology. 2001;286:384–390. doi: 10.1006/viro.2001.1012. [DOI] [PubMed] [Google Scholar]
  • 48.Wool-Lewis R., Bates P. Characterization of Ebola virus entry by using pseudotyped viruses: Identification of receptor deficient cell lines. J Virol. 1998;72:3155–3160. doi: 10.1128/jvi.72.4.3155-3160.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Wool-Lewis R., Bates P. Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function. J Virol. 1999;73:1419–1426. doi: 10.1128/jvi.73.2.1419-1426.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Yang Z. Y., Duckers H. J., Sullivan N. J., et al. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med. 2000;6:886–889. doi: 10.1038/78645. [DOI] [PubMed] [Google Scholar]
  • 51.Yermolina M. V., Wang J., Caffrey M., et al. Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entry. J Med Chem. 2011;54:765–781. doi: 10.1021/jm1008715. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Virologica Sinica are provided here courtesy of Wuhan Institute of Virology, Chinese Academy of Sciences

RESOURCES